GSE239844 crizotinib 7 v 5 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE239844_crizotinib_7_v_5_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE239844_crizotinib_7_v_5_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE239844_crizotinib_7_v_5_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE239844_crizotinib_7_v_5_human_up.

Results found

Linked to

 

Label

Description

 

Gene

HLA complex P5

Gene

H3.7 histone (putative)

Gene

RNA polymerase II subunit J3

Gene

zinc finger protein 839 pseudogene

Gene

HERC2 pseudogene 2

Gene

colorectal neoplasia differentially expressed

Gene

long intergenic non-protein coding RNA 667

Gene

Morf4 family associated protein 1 like 2

Gene

PSMG3 antisense RNA 1

Gene

H2B clustered histone 20, pseudogene


  • Gene

    H3.7 histone (putative)


  • Gene

    RNA polymerase II subunit J3


  • Gene

    zinc finger protein 839 pseudogene


  • Gene

    HERC2 pseudogene 2


  • Gene

    colorectal neoplasia differentially expressed


  • Gene

    long intergenic non-protein coding RNA 667


  • Gene

    Morf4 family associated protein 1 like 2


  • Gene

    PSMG3 antisense RNA 1


  • Gene

    H2B clustered histone 20, pseudogene

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.